Wonbiogen
원바이오젠KRX: 307280· Fiscal year 2025· wonbiogen.co.kr ↗
Average salary
Not disclosed
Employees
77
▲ 6.9% vs 2024
Average tenure
4 yrs
Reference: average annual pay in Healthcare & Pharma, South Korea: $31.4K (고용노동부 사업체노동력조사 2025 (KOSIS DT_118N_MON052), 2025). Official government wage statistics for the whole industry, not this company's pay. Definitions differ by country; see the source.
Workplace
Women's pay (men = 100)69
Women among staff41.6%
Contract staff0%
Recent official filings
- 2026-11-13Quarterly report (2026.09)
Quick read
- Headcount grew by 5 (6.9%) from 2024.
- Revenue grew 15.8% year over year.
- Revenue has grown two years in a row.
- Operating margin was 22.5% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $342.7K
- Net profit per employee
- $62.8K
- Operating margin
- 22.5%
- Net margin
- 18.3%
- ROE
- 15.2%
- Debt-to-equity
- 11.7%
- Equity ratio
- 89.5%
- Payout ratio
- 15.3%
- Dividend per share
- $0
- Dividend yield (as disclosed)
- 2.2%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.